Literature DB >> 9834736

Botulinum A toxin for glabellar wrinkles. Dose and response.

C L Hankins1, R Strimling, G S Rogers.   

Abstract

BACKGROUND: Botulinum A exotoxin injection is a well-established method for treatment of glabellar frown lines, crow's feet, and horizontal furrows of the forehead. However, there is no consensus as to the optimal dosage per injection site or the concentration of injectate to be used.
OBJECTIVE: The purpose of this study was to determine the minimal effective dose per injection site to be used as well as the effect of concentration in response to treatment.
RESULTS: A total of 46 subjects were divided into ten groups and injected with escalating doses and concentrations of botulinum toxin. The response and longevity of treatment were then followed on a monthly basis. A dose between 2.5-4 U per injection site (12.5-20 U total) was determined to be an effective starting dose, with a duration of 2-5 months (median 14 weeks).
CONCLUSIONS: There was no statistically significant difference in safety or efficacy for concentrations ranging from 50 to 200 U/ml of botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834736     DOI: 10.1111/j.1524-4725.1998.tb04095.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

Review 1.  A review of the longevity of effect of botulinum toxin in wrinkle treatments.

Authors:  G Wright; A Lax; S B Mehta
Journal:  Br Dent J       Date:  2018-02-23       Impact factor: 1.626

2.  Botulinum toxin type a for the treatment of hyperkinetic lines of the face.

Authors:  Dinesh Singh Chauhan; K M Cariappa; Yadavalli Guruprasad
Journal:  J Maxillofac Oral Surg       Date:  2012-08-28

3.  Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.

Authors:  John C Bladen; Ilan Feldman; Maribel Favor; Marizol Dizon; Andre Litwin; Raman Malhotra
Journal:  Eye (Lond)       Date:  2018-09-10       Impact factor: 3.775

4.  Botulinum toxin type A for the management of glabellar rhytids.

Authors:  Anne Marie Tremaine; Jerry L McCullough
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-07

Review 5.  AbobotulinumtoxinA: A 25-Year History.

Authors:  Gary D Monheit; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 6.  Botulinum neurotoxin formulations: overcoming the confusion.

Authors:  Souphiyeh Samizadeh; Koenraad De Boulle
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-30

Review 7.  Application of botulinum toxin in maxillofacial field: Part II. Wrinkle, intraoral ulcer, and cranio-maxillofacial pain.

Authors:  Kyung-Hwan Kwon; Kyung Su Shin; Sung Hee Yeon; Dae Gun Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-10-16

8.  Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.

Authors:  Welf Prager
Journal:  Clin Pharmacol       Date:  2013-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.